Impact of Premedication Prior to Platelet Transfusion on Platelet Increment Among Hemato-Oncological Patients

被引：0

作者：

Berger, Tamar ^{[1
,2
,3
]}

Yahalom, Vered ^{[2
,4
]}

Giladi, Odil ^{[1
,2
]}

Kugler, Eithan ^{[1
,2
]}

Shochat, Tzippy ^{[5
]}

Meirman, Victoria ^{[1
]}

Gal, Ella ^{[1
]}

Klebovsky, Tetyana ^{[1
]}

Wolach, Ofir ^{[1
,2
]}

Yeshurun, Moshe ^{[1
,2
]}

Raanani, Pia ^{[1
,2
]}

Shargian, Liat ^{[2
,6
,7
]}

Pasvolsky, Oren ^{[1
,2
,8
]}

机构：

[1] Rabin Med Ctr, Inst Hematol, Davidoff Canc Ctr, Petah Tiqwa, Israel

[2] Tel Aviv Univ, Fac Med, Tel Aviv, Israel

[3] Rockefeller Univ, Lab Genome Maintenance, New York, NY USA

[4] Rabin Med Ctr, Blood Serv & Apheresis Inst, Petah Tiqwa, Israel

[5] Rabin Med Ctr, Bio Stat Unit, Beilinson Campus, Petah Tiqwa, Israel

[6] Rabin Med Ctr, Inst Hematol, Davidoff Ctr, Tel Aviv, Israel

[7] Tel Aviv Univ, Fac Med, Tel Aviv, Israel

[8] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-181310

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

下载

页数：4

共 50 条

[1] Continuous Platelet Transfusion Increases Platelet Increment in Refractory Hemato-Oncological Patients - a Single Center Experience
Tzadok, Sharon
Gurevich, Anna
Inbal, Aida
Bar-Natan, Michal
Wolach, Ofir
Raanani, Pia
BLOOD, 2014, 124 (21)
[2] Platelet antibodies and fever:: Their association in multitransfused patients with hemato-oncological diseases
Kurz, M
Eichelberger, B
Greinix, H
Höcker, P
Kahls, P
Knöbl, P
Mayr, WR
Panzer, S
INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 1999, 26 (01): : 34 - 36
[3] AGONIST-INDUCED PLATELET REACTIVITY CORRELATES WITH BLEEDING IN HEMATO-ONCOLOGICAL PATIENTS
Batman, B.
Van Bladel, E.
Van Hamersveld, M.
Jong, P. Pasker-De
Korporaal, S.
Urbanus, R.
Roest, M.
Boven, L.
Fijnheer, R.
LEUKEMIA RESEARCH, 2017, 61 : S15 - S15
[4] AGONIST-INDUCED PLATELET REACTIVITY CORRELATES WITH BLEEDING IN HEMATO-ONCOLOGICAL PATIENTS
Batman, B.
van Bladel, E. R.
van Hamersveld, M.
Pasker-de Jong, P. C.
Korporaal, S. J.
Urbanus, R. T.
Roest, M.
Boven, L. A.
Fijnheer, R.
HAEMATOLOGICA, 2017, 102 : 832 - 833
[5] The role of pathogen-reduced platelet transfusions on HLA alloimmunization in hemato-oncological patients
Saris, Anno
Kerkhoffs, Jean Louis
Norris, Philip J.
van Ham, S. Marieke
ten Brinke, Anja
Brand, Anneke
van der Meer, Pieter F.
Zwaginga, Jaap Jan
TRANSFUSION, 2019, 59 (02) : 470 - 481
[6] To Assess Prevalence and Risk Factors Responsible for Platelet Transfusion Refractoriness in Multitransfused Hemato-oncological Patients at Tertiary Care Centre in North India
Kumawat, V.
Sharma, R.
Malhotra, P.
Marwaha, N.
TRANSFUSION, 2010, 50 : 127A - 127A
[7] ESTIMATING THE MICROCOSTS OF BLOOD TRANSFUSION For Hemato-Oncological Patientes
Brilhante, Dialina
Macedo, Ana
Santos, Ana
ACTA MEDICA PORTUGUESA, 2008, 21 (06): : 575 - 580
[8] Altered Fc glycosylation of anti-HLA alloantibodies in hemato-oncological patients receiving platelet transfusions
van Osch, Thijs L. J.
Pongracz, Tamas
Geerdes, Dionne M.
Mok, Juk Yee
van Esch, Wim J. E.
Voorberg, Jan
Kapur, Rick
Porcelijn, Leendert
Kerkhoffs, Jean-Louis H.
van Der Meer, Pieter F.
van Der Schoot, C. Ellen
de Haas, Masja
Wuhrer, Manfred
Vidarsson, Gestur
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (12) : 3011 - 3025
[9] Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience
Gurevich-Shapiro, Anna
Tzadok, Sharon
Rosenberg, Alina
Inbal, Aida
Bar-Natan, Michal
Wolach, Ofir
Raanani, Pia
ACTA HAEMATOLOGICA, 2017, 137 (04) : 183 - 190
[10] Fertility treatment in young hemato-oncological patients
Richter, D.
Mehnert, A.
Geue, K.
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 214 - 214

← 1 2 3 4 5 →